Scilex Holding (SCLX) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026)

Scilex Holding (SCLX) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Scilex Holding 58.57 Mn -91.35 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -36.52%
Dec 31, 2025 79.25%
Sep 30, 2025 -198.79%
Jun 30, 2025 -228.32%
Mar 31, 2025 -147.88%
Dec 31, 2024 913.79%
Sep 30, 2024 92.44%
Jun 30, 2024 7.92%
Mar 31, 2024 -3,232.00%
Dec 31, 2023 60.32%
Sep 30, 2023 -231.58%
Jun 30, 2023 13.64%
Mar 31, 2023 -69.23%
Dec 31, 2022 -181.25%
Sep 30, 2022 223.08%
Jun 30, 2022 -85.71%
Mar 31, 2022 89.23%
Dec 31, 2021 -712.50%
Sep 30, 2021 -700.00%
Jun 30, 2021 -102.56%